In our study, spontaneous ventilation was maintained, 4 whereas in the other, manual support of ventilation was used. 2 Thus, the question arises whether reported values for k e0 can be explained by experimental conditions, including alveolar ventilation and the apparatus used.
Our aim was to predict quantitatively the degree of hysteresis one might expect to find in a study on the dynamic relationship between end-expired sevoflurane and BIS. Using our physiologically based pharmacokinetic model, we systematically studied various determinants of k e0 under conditions that are not feasible in patients. First, we quantified the theoretical hysteresis originating solely from the physiological and pharmacological processes governing the transport of sevoflurane between alveoli and brain. Secondly, we quantified the impact of sources of error on actual measurements of k e0 , such as the time needed to process the EEG and to calculate BIS. We therefore added a pharmacodynamic section to the model.
Methods
The work was not reviewed by an institutional review board because of its theoretical nature. Studies from which we used data, including our own, 4 were approved by appropriate Ethical Committees. Data are expressed as mean (SD), unless stated otherwise.
The basic model
Structure Our model 5 6 describes changes in partial gas pressures with time in a subject attached to a circle breathing system with carbon dioxide absorption. Kinetics of nitrogen, oxygen, carbon dioxide, nitrous oxide, inhaled anaesthetic agents, and helium are calculated. We have modified this existing model. The brain is no longer one compartment supplied by a fixed fraction of cardiac output. The brain is now a two-compartment sub-model, providing a better description of sevoflurane kinetics in those parts of the brain where anaesthetic effects occur (Fig. 1) . A time delay is present between alveolar and brain tensions as the model mimics circulation times in the body by including blood pools (Fig. 1) .
A description, mathematical formulation, and supplementary validation of the new version of the model are given in the on-line supplement. There we have described 10 typical data sets quantifying the sub-model for the Fig 1 Block diagram of the physiologically based model for sevoflurane. The brain has two compartments, each with its own perfusion (Q 1 and Q 2 ), volume (V 1 and V 2 ), and tissue/gas partition coefficient (l 1 and l 2 ). Ten data sets to quantify the two-compartment sub-model for the brain are given in the on-line supplement. The liver compartment includes the liver itself and the whole portal system. The blood pools serve to mimic circulation times in the body (c.v., central venous). 29 Dashed lines represent the impact of arterial tensions of carbon dioxide, sevoflurane, and nitrous oxide on CBF and cardiac output.
Pharmacodynamics in a physiological model brain. However, the characteristics of the two brain compartments may be freely chosen. One can choose either to model grey matter and white matter in various ways or to treat the first brain compartment as a 'sample brain' with negligible volume. Here, we use only the two data sets from Table 1 .
In the new version, cerebral blood flow (CBF) changes by 30% from default within the range 3.33 -10 kPa for each kPa change in arterial partial pressure of carbon dioxide (Pa CO 2 ). 7 8 CBF decreases linearly with the arterial sevoflurane tension with a maximal reduction of 30% at 0.5 MAC. 8 9 For each kPa change in Pa CO 2 , cardiac output changes by 7% from baseline within the range 2.67-8 kPa (details in the on-line document). 10 Body mass, height, age, and gender are inputs to the model and are used to calculate physiological variables. The model was set to simulate a standard human (40-yr-old man of 70 kg body mass and 1.80 m in height), unless stated otherwise.
Alveolar and end-expired partial pressures
A set point for PCO 2 in the 'ideal' alveolar space (PA CO 2 ) is to be chosen and entered in the model. This set point is used to calculate the inspired alveolar ventilation [equation (24) in the work of Lerou and Booij 5 ]. By definition, PA CO 2 equals the arterial CO 2 tension.
End-expired partial pressures are needed for comparison with clinical measurements. Thus, an 'ideal' alveolarend-expired partial pressure difference for CO 2 (DPCO 2 ) is to be chosen. Default DPCO 2 =0.533 kPa. A 'dilution factor', that is, the fraction of dead space gas in end-expired gas, can be deduced: d=DPCO 2 /PA CO 2 . The default dilution factor of 10% is similar to the average d reported [11.58% (range 4.44-23.81%)].
11 This is an acceptable matching of our model to experimental data. 12 13 Simulated end-expired sevoflurane tensions were calculated from the 'ideal' alveolar (PA sev ) and dead space (=inspired; PI sev ) tensions predicted by the model and the dilution factor: PE 0 sev =(12d)/PA sev +dPI sev . 5 
Clinical validation
Predicted sevoflurane tensions were tested against the clinical data of Nakamura and colleagues.
14 They measured sevoflurane tensions in arterial and internal jugular venous blood (the latter reflecting brain tensions). Two scenarios were simulated for their average 56-yr-old male patient of 1.58 m height and 55 kg body mass.
14 Our approach to recreate their experimental conditions is described in the on-line supplement.
The basic model extended with a pharmacodynamic section
The extended model separates the relationship between dose of anaesthetic and effect into two successive processes. The pharmacokinetic section (basic model) describes how, after the introduction of an anaesthetic gas at the upper respiratory tract, partial pressures in the tissues, including grey matter, vary with time. The pharmacodynamic section defines the relationship between the partial pressure of sevoflurane at its effect-site (P e ) and a measure for its anaesthetic effect (E), using four parameters:
where E 0 is the value of the measure when no drug is present (e.g. 100 for BIS); E max , the value when the maximum effect is caused by the drug (e.g. 20 for BIS); and P 50 , the effect-site partial pressure associated with an effect midway between E 0 and E max . The exponent g determines the shape and slope of the sigmoid curve. In equation (1), P e is yet to be defined. There are two distinct ways to calculate P e . The first and obvious way in a physiologically based model is to assume that the calculated grey matter tension (P gm ) represents the tension P e at the effect-site. Alternatively, one may leave physiological fidelity and derive the effect-site partial pressure directly from the calculated alveolar partial pressure P A using the relationship known from pharmacokineticpharmacodynamic models:
Equation (2) implies that the larger the k e0 , the more rapid the approach to equilibrium. Table 1 Two data sets to quantify the two-compartment sub-model of the brain (Fig. 1) . From the 10 data sets presented in the on-line supplement, two sets are given here. Data set #1 traces to the old version of the model where brain perfusion has a uniform distribution as no brain compartments have been discerned. Data set #4 has differential blood flows supplying grey matter and white matter and different tissue/gas partition coefficients. Published experimental data for k e0
We searched the literature for studies on relationships between sevoflurane and measures of its effects on the EEG and noted published values for E 0 , E max , P 50 , g, and k e0 . However, instead of k e0 , some investigators reported 'equilibration half-time' given as:
Equation (3) Figure 3 , we first calculated individual values for k e0 and then the average (SD) k e0 .
Study 1: quantifying theoretical k e0 s
We used the basic model to estimate the unknown theoretical hysteresis which is solely determined by the transport of sevoflurane between alveoli and grey matter. Accordingly, we estimated k e0 from simulated time courses of sevoflurane tensions in the alveolar space and grey matter. We assumed that EEG changes caused by sevoflurane are directly related to its tension in grey matter. This is in fact a model reduction operation illustrated in Figure 2A . The following factors were varied to study their impact on k e0 : alveolar ventilation, blood flows supplying the brain, and delivered sevoflurane concentrations. Blood flows were varied by choosing different data sets to quantify the brain sub-model.
Estimating k e0 involved two steps. First, the basic model was run for 70 min to calculate sevoflurane tensions in response to a varying vaporizer setting (one data point per 5 s). Secondly, the model defined by equation (2) , in which P e was substituted with P gm , was fitted to time courses of sevoflurane tensions in alveoli and grey matter. The value of k e0 was optimized with the Solver tool (Excel, Microsoft) by minimizing the sum of the squared differences between values for P gm calculated by the basic model and those calculated from equation (2) . The k e0 guess value was 0.5 min 21 (no constraints).
Constant ventilation
Thirty-two simulation runs were performed (4Â2Â4) using four constant levels for Pa CO 2 , two data sets quantifying the brain sub-model, and four vaporizer settings. Pa CO 2 was 4, 5.33, 6.67, or 8 kPa. The two data sets are given in Table 1 .
Three vaporizer settings produced a sinusoidal pattern ( period=30 min) of delivered sevoflurane concentration varying between 0 and 0.005, 0.5, or 3 MAC, respectively.
The value of 0.005 MAC represents a trace concentration that does not produce circulatory effects on CBF. Nonrebreathing conditions were used. The fourth vaporizer setting had a staircase pattern: the setting was increased by 1 vol% per 3 min from 0 to 5 vol%. Fifteen minutes after starting the administration, the vaporizer was turned off for 5 min. The sequence was repeated once, after which the vaporizer was turned off. The whole sequence, in conjunction with rebreathing conditions using a fresh-gas flow of 5 litre min 21 , is similar to that used in our separate experimental study. 4 
Varying ventilation
Twelve additional simulation runs used varying alveolar ventilation to mimic ventilatory responses to varying sevoflurane concentrations. The staircase sevoflurane input Fig. 1 ) predicts sevoflurane partial pressures in a number of tissues, including grey matter. The physiological and pharmacological processes underlying the rate of equilibration between alveoli and grey matter may be lumped into an 'effect-site equilibration rate constant' k e0 . Assuming that EEG changes caused by sevoflurane are directly related to its partial pressure in grey matter, one may estimate the unknown theoretical k e0 from the time courses of P A and P gm (encircled variables) predicted by the basic model. (B) Study 2: sensitivity analysis. The extended model was used to study how sensitive experimental estimates for k e0 are to non-ideal conditions. Known values are first assigned to five parameters: k e0 , E 0 , E max , P 50 , and g. Values assigned to k e0 are equal to the theoretical values obtained in study 1. Values for these five parameters are then recovered from the model-predicted time courses of end-expired partial pressures and BIS (encircled variables). A difference between a known assigned value for k e0 and a recovered value depends on the time delays in the monitoring devices and the dilution of alveolar gas by dead space gas. The partial pressure of sevoflurane in dead space gas equals that in inspired gas.
Pharmacodynamics in a physiological model and rebreathing conditions as described earlier were used. The 12 runs (2Â3Â2) used two data sets (Table 1) , three dose -response (D/R) curves for Pa CO 2 vs sevoflurane tension, and two time lags between peak end-expired concentrations of sevoflurane and those of carbon dioxide.
The set point for Pa CO 2 varied in time according to data from Doi and Ikeda. 16 They showed that after 15 min of stable end-expired levels of 1.1 and 1.4 MAC sevoflurane, Pa CO 2 was 6.51 [95% confidence interval (CI)¼6. .74] kPa and 7.31 (95% CI¼7.02-7.60) kPa, respectively. Assuming that ventilation is further depressed at 2 MAC and nearly stops at 2.5 MAC sevoflurane, 17 we chose set points for Pa CO The two time lags between end-expired concentrations of sevoflurane and those of carbon dioxide were 1 and 2.5 min. The set point for Pa CO 2 depended on the sevoflurane tension in grey matter, not in end-expired gas, thus mimicking the physiological time delay between alveoli and respiratory centres. This is in accordance with data from Mapleson and colleagues 18 who described that the same perfusion may apply to the site of action of inhaled anaesthetics or to medullary chemoreceptors. An extra delay was to be introduced to replicate the total time lag we observed in a separate experimental study. 4 For 16 out of 18 patients, we could calculate an unequivocal time lag between the attainment of the first peak end-expired sevoflurane concentration and the ensuing peak end-expired carbon dioxide concentration. 'Physiological' time delay in the basic model was 1 min. The extra delay to be incorporated in the model was 1.5 min, as we had found that total delay was 2.5 (95% CI¼1.4-3.5) min, with a peak sevoflurane concentration of 2.6 (95% CI¼2.4-2.8) vol% and a peak Pa CO 2 of 6.9 (95% CI¼6.6 -7.3) kPa (assuming DPCO 2 ¼0.533 kPa). 4 Study 2: sensitivity analysis Study 1 does not reflect the conditions of a clinical study, as alveoli and grey matter are inaccessible. Experimental k e0 s are derived from end-expired partial pressures and BIS. In study 2, we investigated how sensitive the estimates for k e0 are to dilution of alveolar gas by dead space gas and time delays in data acquisition and analysis. Our strategy, which recreated the methodology of a clinical study, 4 15 is illustrated in Figure 2B . Estimating k e0 involved three steps. First, we assigned known values to the five parameters in the extended model: k e0 , E 0 , E max , P 50 , and g. Secondly, the model was run for 70 min to calculate time courses of end-expired partial pressures and BIS (one data point per 5 s). We used only data set #4 and one forcing function for sevoflurane, that is the staircase function described earlier. Thirdly, we estimated-in fact, here we recovered-values for the five parameters. The model defined by equations (1) and (2) was therefore fitted to time courses of end-expired partial pressures and BIS. Alveolar partial pressures in equation (2) were replaced with end-expired partial pressures. The values of the five parameters were optimized with Solver, minimizing the sum of the squared differences between the values for BIS calculated by the extended model and those calculated from equations (1) and (2) .
We
Two hundred and fifty-six simulation runs were performed (4Â4Â4Â4) using four dilution factors (d=0, 0.1, 0.2, and 0.5), four delays in gas sampling and analysis (0, 5, 10, and 15 s), four delays in EEG processing (0, 15, 30, and 60 s), and four levels of ventilation (constant with Pa CO 2 of 4, 5.33, and 6.67 kPa or varying).
Assigned values for k e0 were not arbitrarily chosen but were the theoretical values found in study 1. Thus, they depended on ventilation: 0.2, 0.35, and 0.53 min 21 for Pa CO 2 of 4, 5.33, and 6.67 kPa, respectively and 0.53 min 21 for a varying Pa CO 2 . Assigned values for E 0 , E max , P 50 , and g were: 95 (enables adding noise without exceeding 100), 20, 1.3 kPa, and 2, respectively. The assigned values were also the guess values for Solver.
Results
Clinical validation of the model Published experimental data Table 2 shows the variation in experimental conditions of published studies. They are arranged in chronological order of appearance and denoted A-H. Our study is denoted Z. There is large variation in devices and algorithms for EEG processing, time windows, and time delays, as well as in methods used to analyse raw data to obtain E 0 , E max , P 50 , g, and k e0 .
Values reported for these five parameters can be compared in Table 3 . k e0 found in Z is much larger than that in other studies. Values reported for t 1/2 are also given, but not translated into k e0 because of inevitable errors (Appendix). However, individual values for t 1/2 could be recovered from 23 digitized data points for BIS from study G. 15 We found a t 1/2 =3.89 (2.57) min, which corresponds very well with the reported t 1/2 =3.9 (2.6) min. Calculating the 23 individual k e0 s [equation (3)] and averaging yielded k e0 =0.34 (0.38) min 21 (Appendix). The median value for k e0 from study D could not be translated into a correct t 1/2 , owing to an even number of subjects.
3 Table 3 shows variance in the values for k e0 not only between studies but also between subjects. The large variance among subjects in study G [coefficient of variation (CV)=0.67] is responsible for the large error it is possible to make while translating the average value for t 1/2 into k e0 (Appendix). SD (two-stage approach) or CV (non-linear mixed effect modelling) reported for t 1/2 cannot be translated into values for dispersion measures for k e0 .
In comparison with k e0 , there is much less variation in P 50 , despite the different experimental conditions (Table 3 ). In contrast, there is gross variation in g with a range between 1.1 and 4.5 for BIS. E 0 and E max values were not always estimated. Table 4 shows that values for k e0 increase substantially with Pa CO 2 . For a given condition, there is a 2.7-to 4.6-fold increase in k e0 when doubling Pa CO 2 from 4 to 8 kPa. Rate constants obtained with data set #4 are larger compared with those obtained with data set #1. Values for k e0 decrease with increasing sevoflurane maxima in the sinusoid forcing functions. Rate constants obtained with a 14 The dashed line is for a uniform perfusion of the brain (data set #1 in Table 1 ). The solid line results from a data set recreating the experimental conditions of Nakamura and colleagues 14 (details are in the on-line supplement). Time is on a logarithmic scale starting at 1 min.
Study 1: quantifying the theoretical k e0 s Constant ventilation
Pharmacodynamics in a physiological model 3 MAC sinusoid forcing function are virtually identical to corresponding rate constants estimated with a staircase vaporizer setting. Table 5 shows that equilibration rate constants estimated during spontaneous ventilation with varying Pa CO 2 do not differ much from those in Table 4 for a constant Pa CO 2 of 6.67 kPa. The impact of the extra time lag is small. Figure 4 displays recovered values for k e0 for a variety of conditions. Each of the four graphs in Figure 4 is devoted to one of the four alveolar ventilations. The impact of a time delay for BIS (t BIS ) or that of a time delay for end-expired concentrations (t EE ) is not shown separately. The results for k e0 could be summarized by plotting against the difference (Dt) between both delays (Dt=t BIS -t EE ). Errors induced by a time delay for BIS are reduced by a time delay for end-expired concentrations in the common situation that t BIS is greater than t EE .
Varying ventilation

Study 2: sensitivity analysis
'True' values for k e0 could be regained without noticeable error if alveolar gas is not contaminated with dead space gas (d=0) and if Dt is zero (Fig. 4A -D) . Absolute values for k e0 decrease with increasing Dt and d. For Pa CO 2 =5.33 kPa, Dt=30 s and d=0.2, the apparent k e0 %0.25 min 21 , that is, a -30% deviation from the 'true' value (Fig. 4B) .
Recovered values for E 0 , E max , and P 50 deviated by no more than 10% for all conditions of Pa CO 2 , d, and Dt, except for d=0.5 where deviations up to 18% were found. Percentage deviations for the parameter g were less than 10% for Dt,25 s, but increased up to 28% with increasing Dt.
Discussion
The new validated version of our model describes sevoflurane kinetics in those parts of the brain where Table 3 Published results for k e0 , t 1/2 , E 0 , E max , g, and P 50 [for symbols see text near equations (1) and (2)] for BIS, spectral edge frequency at the 95th percentile of the EEG power spectrum (SEF 95 ), state entropy (SE), and response entropy (RE). In studies using the two-stage approach (TSA), data are given as arithmetic mean (SD) or as median (25- Table 4 Theoretical equilibration rate constants k e0 (min 21 ) for grey matter obtained with controlled ventilation. Alveolar ventilation was adjusted to maintain four different fixed arterial carbon dioxide partial pressures (Pa CO 2 ) . Using data set #1 implies that all brain areas receive the same perfusion, whereas data set #4 accommodates for grey matter and white matter with their specific perfusion characteristics (Table 1) anaesthetic effects occur. Using this model, we quantified the delay one might expect to find, in a clinical study, between changes in end-expired sevoflurane concentrations and BIS. The magnitude of this delay may be traced to two main sources.
In study 1, we assessed the contribution of the transport of sevoflurane between alveoli and grey matter. As a result of an increased CBF, a higher arterial carbon dioxide tension leads to more rapid approach to equilibrium between alveolar and brain tensions, characterized by a larger k e0 . Theoretical k e0 s range from 0.2 to 0.7 min 21 for an arterial carbon dioxide tension from 4 to 8 kPa. For sevoflurane-depressed spontaneous ventilation, k e0 is 0.53 min 21 . In study 2, we assessed the contributions of end-expired -alveolar differences and time delays occurring in devices for EEG processing and gas analysis. The difference in these time delays (Dt) proved to affect the experimental estimation of the theoretical values defined in study 1. As Dt is greater than zero in most circumstances (Dt=t BIS -t EE ), measured k e0 is smaller than theoretical values, thus suggesting an erroneously slow brain wash-in. The deviation further increases with an increasing dilution factor. For normocapnia, apparent k e0 s are approximately 10-35% smaller than the theoretical values for any Dt between 0 and 60 s with a dilution factor of 0.1. For sevoflurane-depressed spontaneous ventilation, one may expect to find a k e0 between 0.51 and 0.40 min 21 for any Dt between 5 and 20 s with any dilution factor between 0 and 0.1.
Factors influencing k e0 have been categorized previously. 2 19 The list includes: (i) time needed for gas sampling and computing end-expired concentrations; (ii) end-expired to arterial tension differences; (iii) cardiac output-dependent transit time to the brain; (iv) anaesthetic wash-in and wash-out of the effect-site (depending on volume, perfusion, and partition coefficients); (v) neuronal dynamics; and (vi) time needed for parameter computing by the EEG device. The fifth factor was not incorporated in our model, on the assumption that its role is minimal in comparison with other factors.
This comprehensive list lacks the quantitative evaluation of the present study. The list does not recognize that the difference in time delays between monitoring devices for EEG processing and gas analysis plays a crucial role. Measurement error can even be minimized by similar delays. Inspired sevoflurane tensions are not explicitly mentioned, although they may grossly influence k e0 by determining CBF (Table 4) .
The k e0 of 0.48 min 21 we report for spontaneously breathing patients 4 agrees well with the expected value. Pilge and colleagues 20 reported that the average delay is 19 s for BIS values changing with small steps and BIS.20, which are conditions similar to those in our study Z. We defined empirically an average delay for end-expired concentrations of 8 s. Thus, with Dt=11 s, the range of expected k e0 s is 0.4920.45 min 21 for any d=0 -0.05 (Fig. 4C ). This range encompasses our experimental k e0 of 0.48 min
21
. A small dilution factor d is consistent with the condition that gas was sampled from a nasal catheter and not from the facemask via an elbow adapter. 4 The k e0 values obtained in four studies which aimed at normocapnia are also within the expected ranges. The k e0 for BIS was 0.31 and 0.34 min 21 in studies F and G, respectively. The theoretical k e0 is 0.35 min
, but Figure 4B shows that it is likely to obtain estimates between 0.31 and 0.34 min
, if d is small and Dt is between 20 and 0 s. Exact data on Dt are not available, but a Dt of 10 s would be compatible with data from study G. In study D, k e0 is 0.23 min 21 . This value may be expected as Figure 4B shows that for Dt=30 s (not an unlikely situation with the older A-1000 device) and d=0.2, the theoretical value of 0.35 min 21 turns into an expected 0.25 min
. In study E, k e0 is 0.41 min 21 for SEF 95 . The discrepancy with BIS may be explained by a larger delay for BIS, which is consistent with the longer computation time needed for BIS.
We did not discuss data from studies that reported only average equilibration half-times (Table 3) because of the possible error associated with converting a group mean t 1/2 into a k e0 . The exact error is unclear when investigators directly convert average values for k e0 in t 1/2 or vice versa, in an attempt to compare their data with those of others. 1 21 As there is evidence that the error could be more than trivial (Appendix), we propose that published results should always include values for k e0 .
The model does not include carbon dioxide transport and storage. This has no consequences for the vast majority of simulations where we assumed that a steady 16 To reproduce data from our separate experimental study Z, 4 an extra time lag of 1.5 min was incorporated between the attainment of a sevoflurane tension in grey matter and the ensuing target Pa CO 2 . Using data set #1 implies that all brain areas receive the same perfusion, whereas data set #4 accommodates for grey matter and white matter with their specific perfusion characteristics (Table 1 Pharmacodynamics in a physiological model state with a chosen Pa CO 2 was reached before administering sevoflurane. For simulations with sevoflurane-depressed spontaneous ventilation, we matched the time lag in the model (between peak end-expired concentration of sevoflurane and that of carbon dioxide) to that in our measurements. 4 This is a well-known solution in the absence of sufficient data to build a perfect physiological model.
Although more of our own data could have been introduced into the model, depression of alveolar ventilation was based on other published data. 16 Predicted peak end-expired concentrations of carbon dioxide agreed with those measured. The impact of the extra time lag was small (Table 5) .
Previous publications have suggested that physiologically based models incorrectly represent the uptake of inhaled anaesthetics by the brain as the predicted halftimes were shorter than those measured. Nakamura and colleagues 14 proposed to eliminate discrepancies between their clinical data and their own four-compartment model by assuming a brain partition coefficient twice as great as the accepted one. Others 22 have postulated controversial 23 24 'barriers' between alveolar gas and blood and between blood and brain. Investigators calculated half-times using a chosen fixed CBF. However, experimental brain uptake depends on a CBF that may differ from that assumed and may vary dynamically (on-line supplement). Our results suggest that a model can explain clinical data without postulating concepts that are not consistent with previous evidence. Others have suggested alternative explanations, such as the combination of diffusion limitation and local shunt in the brain. 25 Confidence is justified when the modified model is used for an analytical separation of the factors contributing to erroneous estimations of k e0 . The model's credibility is related to the fact that surrogate measures of anaesthetic effects are indirect estimations of perfusion and sevoflurane tension in inaccessible parts of the central nervous system. 18 The model describes sevoflurane tensions in grey matter where anaesthetic effects occur. For both the wash-in into the brain (Fig. 3) and the effects of sevoflurane on BIS, agreement was observed between theory and experiment. Thus, each gives further confidence in the validity of the other.
In conclusion, published data for k e0 are similar to theoretical values after correction for investigation-specific experimental conditions. Uncorrected k e0 s for BIS suggest an erroneously slow wash-in of grey matter. Experimental conditions and interpatient variability, caused, for example, by variation in the dilution factor d, grossly influence the experimental results. As a corollary, there may be no unique k e0 , but there may only be a k e0 for a unique patient under unique conditions.
Supplementary material
A comprehensive description of the development of the new version of the model and more simulations can be found as supplementary material in British Journal of Anaesthesia online. Table A1 Experimental and synthetic data. The individual experimental data for t 1/2 obtained from study G (Tables 1 and 2 ) were converted into individual values for k e0 using equation (3) . The three synthetic data sets for k e0 were obtained by simulation and have a CV of approximately 1/3, 2/3, and 1 (CV=SD/mean) (details in Appendix). n, number of individual observations Pharmacodynamics in a physiological model
